Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Speculation...
Yes, no question Pohl has to present our company to analysts.  IMO he may be waiting for the warrant issue to be resolved.  I'm hoping he will give a presentation before the Markman however... even if funds can't buy it now the managers can start accumulating for themselves as they become aware of this story.  That way, if we have a successful Markman, they'll be ready to make the plunge.  With a successful Markman, $5.00 should be fairly easy to attain.  JMO of course.
Share
New Message
Please login to post a reply